Trade Desk profits from Google’s delay on cookie phaseout
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AeroVironment shares drop after earnings report
AeroVironment, a drone and robotics company with its chief operations in Simi Valley, delivered record revenue in the fourth quarter and full year of 2021, according to earnings released June 29, but a couple of key losses led to a year-to-year earnings drop. In the fourth quarter of its 2021 fiscal year, AeroVironment posted a Read More →
Water agencies file suit against Santa Barbara County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
UCLA Health continues northward march
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
CSUCI, SBCC get multimillion-dollar gifts from MacKenzie Scott
Amazon billionaire MacKenzie Scott gave away another $2.7 billion on June 15, including $20 million for Santa Barbara City College and $15 million for CSU Channel Islands near Camarillo. Scott announced the new round of gifts with a blog post that lists all 286 recipients, most of them public institutions and private nonprofits in higher Read More →
Region’s universities strive for workplace inclusiveness
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s new drug could be a blockbuster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
